Full View

Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD

KF Rabe, FJ Martinez, GT Ferguson… - … England Journal of …, 2020 - Mass Medical Soc
Background Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …
被引用次数：467 相关文章

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.

KF Rabe, FJ Martinez, GT Ferguson… - The New England …, 2020 - europepmc.org
Background Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β 2-agonist (LABA) for chronic obstructive …

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

KF Rabe, FJ Martinez, GT Ferguson, C Wang… - NEW ENGLAND …, 2020 - fair.unifg.it
BACKGROUND: Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

KF RABE, FJ MARTINEZ… - … England Journal of …, 2020 - observatorio.fm.usp.br
BACKGROUND Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting beta (2)-agonist (LABA) for chronic …

Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD

KF Rabe, FJ Martinez, GT Ferguson… - NEW ENGLAND …, 2020 - irinsubria.uninsubria.it
BACKGROUND Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

KF Rabe, FJ Martinez, GT Ferguson… - The New England …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β 2-agonist (LABA) for chronic obstructive …

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

KF Rabe, FJ Martinez, GT Ferguson… - New England …, 2020 - research.manchester.ac.uk
BACKGROUND Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …

[引用][C] Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

KF Rabe, FJ Martinez, GT Ferguson, C Wang… - New England Journal …, 2020 - cir.nii.ac.jp
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[PDF] des-pneumo.org

[PDF][PDF] Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

KF Rabe, FJ Martinez, GT Ferguson, C Wang, D Singh… - 2020 - des-pneumo.org
BACKGROUND Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …
[PDF] uclouvain.be

[PDF][PDF] Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

KF Rabe, FJ Martinez, GT Ferguson, C Wang… - N Engl J …, 2020 - dial.uclouvain.be
BACKGROUND Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …